Moving from Paper-Based Data to EDC: Getting Ready OVERVIEW EDC and Getting Ready for Migration As the biopharmaceutical industry continues its transition to electronic data capture (EDC), the days of paper-based clinical trials are numbered. Driving this trend are factors such as lengthy study start-up time, high incidence of queries and drawn-out database lock, all linked to inefficient paper-based processes. Datatrak addresses these challenges by improving data quality and making them visible faster, enabling real- time safety reviews, and allowing sponsors and contract research organizations (CROs) to better assess the safety profile of a drug as it is being developed. These well-established benefits of EDC have resulted in an estimated 60% of new clinical

Join for free to read